A
Alfredo Adán
Researcher at University of Barcelona
Publications - 249
Citations - 4446
Alfredo Adán is an academic researcher from University of Barcelona. The author has contributed to research in topics: Uveitis & Visual acuity. The author has an hindex of 34, co-authored 234 publications receiving 3445 citations. Previous affiliations of Alfredo Adán include ETSI & University of Duisburg-Essen.
Papers
More filters
Journal ArticleDOI
Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies.
Jose G Ruiz de Morales,Lluís Puig,Esteban Daudén,Juan D. Cañete,José L. Pablos,Antonio Olveira Martín,Carlos González Juanatey,Alfredo Adán,Xavier Montalban,Natalia Borruel,Guillermo Ortí,Esther Holgado-Martín,Carolina Garcia-Vidal,Cynthia Vizcaya-Morales,Víctor Martín-Vázquez,Miguel A. González-Gay +15 more
TL;DR: A comprehensive review of the literature and analysis of the most outstanding evidence have provided the basis for discussing the most relevant data related to IL-17A blocking agents for the treatment of different disorders, such as psoriasis, psoriatic arthritis, rheumatoid arthritis, ankylosing spondylitis, cardiovascular disorders and solid cancer.
Journal ArticleDOI
Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III
Eric B. Suhler,Alfredo Adán,Antoine P. Brézin,Eric Fortin,Hiroshi Goto,Glenn J. Jaffe,Toshikatsu Kaburaki,Michal Kramer,Lyndell L Lim,Cristina Muccioli,Quan Dong Nguyen,Joachim Van Calster,Luca Cimino,Martina Kron,Alexandra P. Song,Jianzhong Liu,Sophia Pathai,Anne Camez,Ariel Schlaen,Mirjam E.J. van Velthoven,Albert T. Vitale,Manfred Zierhut,Samir R. Tari,Andrew D. Dick +23 more
TL;DR: Patients with active Uveitis at study entry who received adalimumab therapy were likely to achieve quiescence, improve visual acuity, and reduce their daily uveitis-related systemic corticosteroid use.
Journal ArticleDOI
Anti-Interleukin-6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis-Associated Uveitis Refractory to Anti-Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty-Five Patients.
Vanesa Calvo-Río,Montserrat Santos-Gómez,Inmaculada Calvo,M. Isabel González-Fernández,Berta López-Montesinos,Marina Mesquida,Alfredo Adán,Maria Victoria Hernández,O. Maíz,Antonio Atanes,B. Bravo,Consuelo Modesto,Gisela Díaz-Cordovés,Natalia Palmou-Fontana,Javier Loricera,María Carmen González-Vela,R. Demetrio-Pablo,José L. Hernández,Miguel A. González-Gay,Ricardo Blanco +19 more
TL;DR: In this article, the authors conducted a multicenter study of patients with JIA-associated uveitis that was refractory to conventional immunosuppressive drugs and anti-tumor necrosis factor (anti-TNF) agents.
Journal ArticleDOI
Tocilizumab treatment for refractory uveitis-related cystoid macular edema
Alfredo Adán,Marina Mesquida,Victor Llorenç,Gerard Espinosa,Blanca Molins,Maria Victoria Hernández,Laura Pelegrín +6 more
TL;DR: These data suggest that TCZ is effective for treating CME in otherwise treatment-refractory cases of uveitis.
Journal ArticleDOI
Anti-TNF-α therapy in patients with refractory uveitis due to Behçet’s disease: a 1-year follow-up study of 124 patients
Vanesa Calvo-Río,Ricardo Blanco,Emma Beltrán,Juan Sánchez-Bursón,Marina Mesquida,Alfredo Adán,Maria Victoria Hernández,Marisa Hernandez Garfella,Elia Valls Pascual,Lucía Martínez-Costa,Agusti Sellas-Fernández,Miguel Cordero Coma,Manuel Díaz-Llopis,Roberto Gallego,David Salom,José Luis García Serrano,Norberto Ortego,José M. Herreras,Alejandro Fonollosa,Ángel García-Aparicio,O. Maíz,Ana Blanco,Ignacio García-De La Torre,Cruz Fernández-Espartero,Vega Jovani,Diana Peiteado-Lopez,Esperanza Pato,Juan Cruz,Carlos Marras Fernandez-Cid,Elena Aurrecoechea,M A García,M.A. Caracuel,Carlos Montilla,Antonio Atanes,Félix Francisco Hernandez,Santos Insua,Senén González-Suárez,Amalia Sánchez-Andrade,Fernando Gamero,L. Linares,Fredeswinda Romero-Bueno,A Javier García,Raquel Almodóvar,Enrique Minguez,Carmen Carrasco Cubero,Alejandro Olivé,J. Vazquez,Oscar Ruiz Moreno,Fernando Jiménez-Zorzo,Javier Manero,Santiago Muñoz Fernández,Javier Rueda-Gotor,Miguel A. González-Gay +52 more
TL;DR: Anti-TNF-α therapy is effective and relatively safe in refractory BD uveitis and the best-corrected visual acuity and the suppression load also showed significant improvement.